Royal Bank Of Canada Night Hawk Biosciences, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$0.15 - $0.45 $36 - $110	245 New	245 $0
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.51 $3 - $6	-13 Reduced 5.04%	245 $0
Q3 2023 Nov 14, 2023	SELL	$0.5 - $0.72 $3 - $5	-7 Reduced 2.64%	258 $0
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.87 $164 - $230	265 New	265 $0
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.62 $142 - $299	-185 Reduced 96.35%	7 $0
Q3 2022 Nov 14, 2022	BUY	$1.79 - $2.96 $343 - $568	192 New	192 $0
Q4 2021 Feb 14, 2022	SELL	$3.04 - $6.01 $6,080 - $12,020	-2,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $2,950 - $3,720	500 Added 33.33%	2,000 $12,000
Q2 2021 Aug 16, 2021	BUY	$5.78 - $9.6 $8,670 - $14,400	1,500 New	1,500 $10,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.